Recombinant Mouse GOLIM4 Protein

• Cat.No.: GOLIM4-7066M
• Product Overview: Recombinant Mouse GOLIM4 full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Mouse
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 ºC for short term. For long term storage, store it at -20 ºC～-80 ºC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: Golim4 golgi integral membrane protein 4 [ Mus musculus ]
• Official Symbol: GOLIM4
• Gene ID: 73124
• mRNA Refseq: NM_175193.5
• Protein Refseq: NP_780402.1
• UniProt ID: Q8BXA1

Reviews

11/17/2022

Its superior purity and stability ensure reliable and reproducible results, providing me with confidence in the integrity of my experiments.

11/03/2022

Whether I am investigating protein-protein interactions, studying enzymatic activity, or conducting protein structure analyses, the ARSG protein consistently delivers exceptional performance and accurate results.

09/12/2019

Its impeccable purity and stability ensure accurate and reproducible results, giving me confidence in the reliability of my research outcomes

Q&As

Can GOLIM4 be targeted for drug development?

Yes, GOLIM4 is being explored as a potential target for drug development in various diseases, including cancer and neurodegenerative disorders.

Is GOLIM4 involved in drug resistance mechanisms?

There is evidence to suggest that GOLIM4 may be involved in drug resistance in certain types of cancer, making it a potential target for overcoming resistance.

Are there any specific antibodies targeting GOLIM4 for research or clinical use?

Yes, specific antibodies against GOLIM4 are being developed for research and potential clinical applications, such as diagnostic assays.

Are there any clinical trials involving GOLIM4?

Clinical trials investigating the role of GOLIM4 in cancer and other diseases are ongoing, aiming to understand its potential as a therapeutic target.

How is GOLIM4 being targeted in cancer therapy?

Experimental therapies targeting GOLIM4 are being explored as potential strategies to inhibit cancer progression and metastasis.